160 related articles for article (PubMed ID: 22202202)
1. Liquid antisolvent precipitation process for solubility modulation of bicalutamide.
Meer TA; Sawant KP; Amin PD
Acta Pharm; 2011 Dec; 61(4):435-45. PubMed ID: 22202202
[TBL] [Abstract][Full Text] [Related]
2. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
Li C; Li C; Le Y; Chen JF
Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
Sancheti PP; Vyas VM; Shah M; Karekar P; Pore YV
Pharmazie; 2008 Aug; 63(8):571-5. PubMed ID: 18771004
[TBL] [Abstract][Full Text] [Related]
4. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
5. Nanosized bicalutamide and its molecular structure in solvents.
Le Y; Ji H; Chen JF; Shen Z; Yun J; Pu M
Int J Pharm; 2009 Mar; 370(1-2):175-80. PubMed ID: 19101616
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
[TBL] [Abstract][Full Text] [Related]
7. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
Dalvadi H; Parmar K; Yadav S
Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
[TBL] [Abstract][Full Text] [Related]
8. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.
Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM
Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420
[No Abstract] [Full Text] [Related]
9. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
[TBL] [Abstract][Full Text] [Related]
11. Analysis of nucleation kinetics of poorly water-soluble drugs in presence of ultrasound and hydroxypropyl methyl cellulose during antisolvent precipitation.
Dalvi SV; Dave RN
Int J Pharm; 2010 Mar; 387(1-2):172-9. PubMed ID: 20026199
[TBL] [Abstract][Full Text] [Related]
12. Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress.
Szafraniec J; Antosik A; Knapik-Kowalczuk J; Chmiel K; Kurek M; Gawlak K; Paluch M; Jachowicz R
Int J Pharm; 2018 May; 542(1-2):18-26. PubMed ID: 29481948
[TBL] [Abstract][Full Text] [Related]
13. Monitoring the Dissolution Mechanisms of Amorphous Bicalutamide Solid Dispersions via Real-Time Raman Mapping.
Tres F; Patient JD; Williams PM; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
Mol Pharm; 2015 May; 12(5):1512-22. PubMed ID: 25872658
[TBL] [Abstract][Full Text] [Related]
14. Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide.
Szafraniec J; Antosik A; Knapik-Kowalczuk J; Kurek M; Syrek K; Chmiel K; Paluch M; Jachowicz R
Int J Pharm; 2017 Nov; 533(2):470-479. PubMed ID: 28363855
[TBL] [Abstract][Full Text] [Related]
15. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
[TBL] [Abstract][Full Text] [Related]
16. Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-L-lactide) block copolymers for drug delivery.
Danquah M; Fujiwara T; Mahato RI
Biomaterials; 2010 Mar; 31(8):2358-70. PubMed ID: 20018369
[TBL] [Abstract][Full Text] [Related]
17. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
Dong Y; Ng WK; Hu J; Shen S; Tan RB
Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
Nageswara Rao R; Narasa Raju A; Narsimha R
J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation.
Dong Y; Ng WK; Shen S; Kim S; Tan RB
Int J Pharm; 2009 Jun; 375(1-2):84-8. PubMed ID: 19481693
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
